ZURICH (Reuters) – Germany’s CureVac filed in Switzerland for a rolling review of its COVID-19 vaccine candidate, the Swiss drugs regulator Swissmedic said on Monday, as yet another maker of...

New pills to treat patients with COVID-19 are currently in midstage clinical trials and, if successful, could be ready by the end of the year. Only one treatment — remdesivir (Veklury) — has been fully...

ZURICH (Reuters) – Novartis’s uphill struggle to re-purpose its inflammation drug Ilaris took another hit when the Swiss drugmaker said on Tuesday that the medicine failed to boost overall...